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ABSTRACT
Sequences with the potential to form RNA G-
quadruplexes (G4s) are common in mammalian in-
trons, especially in the proximity of the 5′ splice site
(5’SS). However, the difficulty of demonstrating that
G4s form in pre-mRNA in functional conditions has
meant that little is known about their effects or mech-
anisms of action. We have shown previously that two
G4s form in Bcl-X pre-mRNA, one close to each of
the two alternative 5’SS. If these G4s affect splic-
ing but are in competition with other RNA structures
or RNA binding proteins, then ligands that stabilize
them would increase the proportion of Bcl-X pre-
mRNA molecules in which either or both G4s had
formed, shifting Bcl-X splicing. We show here that a
restricted set of G4 ligands do affect splicing, that
their activity and specificity are strongly dependent
on their structures and that they act independently at
the two splice sites. One of the ligands, the ellipticine
GQC-05, antagonizes the major 5’SS that expresses
the anti-apoptotic isoform of Bcl-X and activates the
alternative 5’SS that expresses a pro-apoptotic iso-
form. We propose mechanisms that would account
for these see-saw effects and suggest that these ef-
fects contribute to the ability of GQC-05 to induce
apoptosis.
INTRODUCTION
G-rich sequences were irst identiied as functional elements
in pre-mRNA splicing when G-triplets were found to be en-
riched in short introns, where they stimulate splicing and,
in particular, the use of adjacent upstream 5′ splice sites
(5’SSs) (1). Subsequently, they have been shown to be en-
riched in introns of all sizes, especially near the 5’SS, where
they are thought to buffer 5’SS sequences against the effects
of mutations (2). G-rich elements have been shown to facili-
tate the recruitment of U1 and U11 snRNPs (3–5). G-tracts
can be bound directly by hnRNPs F and H (6–9), and it is
likely that these proteins participate in the recruitment of
snRNPs (5). HnRNP H is also implicated when these se-
quences act in other contexts as silencers (10–12) or to im-
prove the splicing of long introns via the juxtaposition of
distant G-tracts (13).
When G-rich sequences are extensive, they have an-
other potential property, that of folding into four-stranded
quadruplex structures (G4s) (14–16). These are stacks in
which each plane comprises four guanines connected in a
ring by Hoogsteen base-pairing. Four G-triplets in reason-
able proximity, therefore, might form a G4 structure with
three such rings in a stack. These structures readily form
in vitro and can be characterized by analysis of short RNA
oligonucleotides (17,18). However, although sequences with
the potential to form such structures have been shown to
affect the splicing of a number of pre-mRNAs (19–27), it
has been dificult to prove that the G4s form in the con-
text of long RNA molecules in functional splicing condi-
tions, where their formation might face competition with
secondary structures or the binding of proteins (18,28). We
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have recently developed a new method based on the use
of deazaguanine-substituted RNA (FOLDeR) by which we
have shown that two G4s form in functional conditions in
Bcl-X pre-mRNA in the G-rich tracts adjacent to the two
alternative 5’SS of exon 2 (29).
The proportion of molecules with G4-forming potential
that contain G4 structures at any one time is hard to es-
timate. For example, immunostaining assays have detected
RNAG4s in the cytoplasm of cells (30), but chemical mod-
iication experiments have shown that G4s that could form
in vitro were largely unfolded in cells (31). This was at-
tributed to competition with RNA-binding proteins. In-
deed, we have shown previously that an artiicial enhancer
comprising repeats of a binding site for SRSF1, GGA, is
able to adopt any of three distinct states, a G4 or complexes
with either hnRNP F/H or SRSF1, and we suggested that
these states were in dynamic equilibrium (18). Similarly, we
have shown that hnRNP F/H binding and G4 formation
were mutually exclusive (9,32), and a silencer in intron 1 of
proinsulin has been shown to be in equilibrium between a
G4 and a stem-loop structure (23). This is a very impor-
tant point. If G4s form in only a minority of candidate se-
quences at any one time but there is an equilibrium, then
the proportion of RNA forming a G4 should be increased
by the addition of G4-stabilizing ligands. This might lead to
signiicant shifts in reactions sensitive to G4 formation. We
have tested this usingBcl-Xpre-mRNA, and show thatwell-
known DNA G4-stabilizers produce diverse effects. This is
indicative of these molecules engaging with deined molec-
ular targets. Some of these shift splicing from the dominant
anti-apoptotic Bcl-XL isoform to the pro-apoptotic Bcl-XS
isoform, while others have no effect on splicing. The active
molecules are all from the ellipticine or quindoline classes,
with fused tetracyclic cores and show differential effects on
the two alternative splice sites according to the core and
speciic substituent groups. We further demonstrate that
the most effective molecule interacts with and acts via the
G4-forming sequences of Bcl-X pre-mRNA, and a prelim-
inary structure-activity comparison suggests that speciic
G4-binding molecules have the potential to control splice
site selection by acting at a subset of G4 structures.
MATERIALS AND METHODS
Synthesis of ellipticine and quindoline analogs
The syntheses and analytical characterizations of the quin-
doline series and the ellipticine analogs GQC-05 GSA1112
and GSA1125 have been described (33,34). The synthesis
and characterization of GSA-1113, GSA-1126, GSA-1133
and GSA-1135 is described in Supplementary Data.
In vitro transcription and splicing of RNA
In vitro transcription and splicing were done as described
(35) using nuclear extracts from Cilbiotech. In brief, pre-
mRNAwas transcribed by T7RNApolymerase in the pres-
ence ofGpppG (to form the 5′ cap) and [-32P]GTP and pu-
riied on a denaturing gel. Splicing assays were done in 10l
reactions by adding 1 l of RNA to pre-aliquoted reaction
mixtures in microtiter plates. Reactions were incubated for
2 h at 30◦C, processed in the microtiter plate and analyzed
by denaturing gel electrophoresis. After analysis by a phos-
phor imager, quantiication of pre-mRNAand bothmRNA
products was done using OptiQuant software, and intensi-
ties were normalized to account for the number of guanines
in each RNA species.
Analysis of splicing complex formation
Splicing complex formation was done as described (36) us-
ing nuclear extracts from Cilbiotech. Samples were incu-
bated for 0, 5, 10, 15, 20, 25 and 30 min, and then incubated
with heparin at 0.8 mg/ml for 30 min at ambient temper-
ature. An equal volume of loading dyes (50 mM Tris base,
50 mM glycine, 40% glycerol, xylene cyanol and bromophe-
nol blue) was added and samples run on a 2% native LMP
agarose gel (50 mMTris base, 50 mM glycine) at 5 V/cm for
6 h at 4◦C. The gel was then compressed, dried and exposed
to a phosphorimager screen.
RNase digestion and primer extension
Transcripts were digested with ribonucleases T1 (Roche),
T2 (Ambion) or VI (Mobitech) and the sites of cleavage
detected using primer extension, as described (29). The
phosphor image was analyzed using SAFA (37) and sig-
niicant changes calculated by using the logarithms of the
following ratio or index to analyze each nucleotide posi-
tion: [V1(10 M GQC-05)/V1(no GQC-05)]/[T2(10 M
GQC-05)/T2(no GQC-05)]. The mean and standard devi-
ation were calculated for the log(Index) values for all posi-
tions analyzed, and positions at which the log(Index) value
deviated from the mean by more than two standard devia-
tions were considered to have shown signiicant changes.
Fluorescence assays
A total of 1 MRNA and 20 MGQC-05 were mixed in a
Hellma luorescence cuvette (Suprasil® quartz, limit 200–
2500 nm spectral range, pathlength 10 × 2 mm, chamber
volume 100 l) and luorescence spectra were obtained on a
FluoroMax-4 spectroluorometer at room temperature with
excitation at 321 nm.
Treatment of cells with G4 ligands
HeLa cells at 70% conluency were incubated with po-
tential G4-stabilizing reagents at 10 M for 4 h. RNA
was extracted and analyzed by reverse transcription-
PCR, with 45 cycles of ampliication, followed by




Figure 1 shows a secondary structure of Bcl-X-681, an in
vitro splicing substrate that comprises the 3′ half of Bcl-X
exon 2, including both alternative 5′ splice sites (SSs), the
adjacent 180 nucleotides (nts) of intron 2, the 3′ 61 nts of
intron 2 and the 5′ part of exon 3 (29). Both 5’SS are used
in vitro but, as with the endogenous gene, the downstream
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Figure 1. Organization and secondary structure of the Bcl-X-681 pre-mRNA. (A) Organization of the Bcl-X-681 transcript. XL and XS 5
′ splice sites
are indicated above the diagrams. (B) Experimentally determined secondary structure and location of the Q2 and Q5 G4s in Bcl-X-681 as previously
determined (29).
Bcl-XL isoform predominates (29) (Figure 2, left column).
We determined this structure previously using RNase foot-
printing andRNaseH, showing that it forms in the presence
or absence of nuclear extract; analysis of deazaguanosine-
substituted pre-mRNA showed that, of six regions that
might have had the potential to form G4s, only the regions
marked Q2 and Q5 did so (29).
Certain putative G4 ligands affect Bcl-X splice site selection
More than 800 molecules of various chemical classes have
been described as G4-ligands (38), and a number of these
affect splicing (18,22,24–26). We tested whether G4 lig-
ands would affect the selection of 5’SS in Bcl-X by using
molecules representing various chemical classes of ligands
(Supplementary Figures S1–3; (33,39–45). As illustrated for
four ligands in Figure 2, Quarloxin, Thiolavin T and 360A
had no detectable effects on splicing of Bcl-X-681 in vitro,
whereas splicing was abolished by TMPyP4, Pyridostatin
and Zn-DIGP (Figure 2; Supplementary Table S1 and Fig-
ure S1). In contrast, GQC-05 (NSC 338258; EPED3) and
GSA-0902 had selective but opposite effects: GQC-05 in-
creased the use of the XS 5’SS while GSA-0902 decreased it
(Figure 2; Supplementary Table S1 and Figures S2 and 3).
The effect of GQC-05, an ellipticine derivative developed
to bind a DNA G4 in the c-MYC promoter G4 (39), was
particularly striking. At a concentration of 10 M, GQC-
05 increased usage of the XS splice site with little apparent
change inXL site usage, whereas at 40Magreater increase
in XS splice site usage was accompanied by a decrease in XL
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Figure 2. In vitro splicing of Bcl-X-681 in the presence of representative G4 ligands. (A) Splicing assays were done in triplicate with the designated ligands
at the concentrations shown (M). The ligands were dissolved in 10% DMSO, and controls included samples done in the presence of DMSO at the same
inal concentration of 1%. All the reactions were done at the same time and run on the same gel. (B) The proportion of the mRNA spliced to the XS site
in the reactions above, after correction for the different numbers of labeled nucleotides in the two different molecular species. The error bar shows the
standard deviation.
splice site. This resulted in the proportion of mRNA form-
ing the XS isoform rising from 15 to 80% (Figure 2B).
Since XL splicing is normally the predominant pathway,
the apparent change in XL splice site usage in the pres-
ence of 40 M GQC-05 involved a higher proportion of
molecules of pre-mRNA than did the increase in XS splic-
ing. The effect could be due to a decrease in the eficiency
of splicing from the XL site or an increased level of degra-
dation of the spliced XL mRNA. To distinguish between
these alternatives, we analyzed the effects of GQC-05 on
the assembly of spliceosomes on Bcl-X-681. Native gel elec-
trophoresis of samples taken from splicing reaction mix-
tures at various time intervals showed that spliceosome for-
mation was reduced (Supplementary Figure S4). This is
consistent with the suggestion thatGQC-05 inhibits thema-
jor (XL) splicing pathway.
Structural features of individualG4 ligands determine the tar-
get site and effects
The opposite effects of GQC-05, an ellipticine derivative
and GSA-0902, a quindoline derivative, were remarkable,
given the similarity of their fused tetracyclic cores (Sup-
plementary Figures S2 and 3). To determine the basis for
this discrimination, we tested a range of analogs of GQC-
05. GQC-05 can be divided into its tetracyclic core and the
exocyclic tertiary amine tail, which will be protonated un-
der physiological conditions (Figure 3A). Addition of 9-
hydroxyellipticine suficed to inhibit the downstream XL
5’SS, but it did not stimulate use of the XS 5’SS, whereas
the tertiary amine tail alone had no effect (Figure 3B). The
effect of the 9-hydroxyellipticine is consistent with indepen-
dent effects of GQC-05 at the two 5’SS, indicating that up-
regulation of the XS site is not merely a consequence of
downregulation of the XL site.
Analysis of a range of other ellipticine derivatives (Sup-
plementary Figure S2) revealed some general principles. In-
creasing the steric bulk of the tertiary amine was toler-
ated, as GSA-1125, GSA-1126, GSA-1133 and GSA-1135
showed the same activities as GQC-05, albeit to a lesser ex-
tent (Figure 3C). Unlike the 9-hydroxyellipticine alone, they
stimulated use of the XS 5’SS. GSA-1112 inhibited both
sites, indicating that functionalization of the indole N-H
(R2, position 6) prevents stimulation of the XS 5’SS, but
GSA-1113 had little effect on either site, from which we in-
fer that when R2 is a tertiary amine it blocks the effect on
the XS site and that when R
1 is an ether it prevents the inhi-
bition of theXL 5’SS. In summary, it appears that inhibition
of the XL 5’SS requires the ellipticine core without an ether
at position 9 and that stimulation of the XS 5’SS occurs with
a positively charged tertiary amine at position 9 and an un-
functionalized indole NH in position 6.
We have examined a similar set of quindolines (Supple-
mentary Figures S3 and 5; Supplementary Table S2). None
of these greatly affected the XL 5’SS, from which we infer
that the tetracyclic ellipticine core structure is important
for its inhibition. The XS 5’SS was slightly stimulated by
quindoline itself and slightly more strongly by SYUIQ-5,
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Figure 3. In vitro splicing of Bcl-X-681 in the presence of ellipticines. (A) Diagrams showing the core and tail of GQC-05. (B) Splicing assays done in vitro
in triplicate with GQC-05 and the separate core and tail. The proportion of the mRNA spliced to the XS site is shown below the image, together with the
standard deviation. M, size markers. (C) Splicing assays done in vitro with other ellipticines (Supplementary Figure S2).
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Figure 4. Effects of GQC-05 and other ellipticines on splicing of endoge-
nous Bcl-X transcripts in HeLa cells. The cells were incubated with the
compound at 10 M for 4 h, followed by isolation of the RNA and am-
pliication by reverse transcriptase-PCR. The products were separated by
agarose gel electrophoresis and detected by ethidium bromide. The exper-
iments were done in triplicate. Reactions done in parallel with reaction
mixtures lacking reverse transcriptase were blank and have been omitted.
which has a tertiary amine on ring position 11. It is pos-
sible that this plays a role equivalent to the tertiary amine
on position 9 of the ellipticines. However, the presence of
piperazine rings at position 11 prevented any stimulation
of the XS 5’SS. Indeed, GSA-0902 and GSA-0820 inhibited
the site. These results conirm that the G4 ligands act inde-
pendently at the two sites and that speciic features of the
ligands are required for these effects; the shift in splicing in-
duced by GQC-05 is not the result of binding by a generic
G4 ligand.
To test whether the effects of these molecules were repli-
cated in cells, HeLa cells were incubated with these G4 lig-
ands at 10 M for 4 h and splicing of the endogenous Bcl-X
was analyzed by RT-PCR. The results showed that GQC-05
produced a clear shift toward Bcl-XS (Figure 4 and Supple-
mentary Table S3). GSA-1125 produced a weaker shift, and
the effects of GSA-1133, GSA-1135 and GSA-1126 were
weaker still. As might have been expected from the in vitro
results,GSA-1112 andGSA-1113 had little or no effect. The
other G4 ligands tested produced little or no effect (Supple-
mentaryFigure S6 andTable S3). In the cases ofQuarloxin,
Thiolavin T, 360A and the quindolines, these results were
essentially the same as with the in vitro assays. However,
there was no evidence of the inhibition of splicing seen in
vitro with TMPyP4, Pyridostatin and Zn-DIGP.
Since GQC-05 showed amuch stronger effect than any of
the other candidates, further work was done with this ellip-
ticine.
GQC-05 interacts with the G4 regions of Bcl-X pre-mRNA
The ability of GQC-05 to alter usage of both splice sites
might involve direct interactions with the Q2 and Q5 G4-
forming sequences, but it was also possible that the effects
were indirect consequences of interactions with splicing fac-
tors. To test whether GQC-05 binds directly to Bcl-X-681
pre-mRNA, its luorescence was measured in the presence
of the RNA. The intensity of luorescence of GQC-05 upon
excitation at 321 nm was increased 15-fold by the addition
of Bcl-X-681 RNA, and the emission peak shifted from
493 to 558 nm (Figure 5A). This is consistent with direct
binding. Furthermore, only the XS and XL domains, which
contain Q2 and Q5, respectively, were bound by GQC-05,
whilst the intron and 3’SS domains produced relatively lit-
tle change. This is consistent with interactions with the G4-
forming sequences.
To map the sites of interaction, RNA footprinting assays
of Bcl-X-681 RNA were done in the presence of increas-
ing concentrations of GQC-05 (Figure 5B, Supplementary
Data). The intensities of the primer extension products fol-
lowing nuclease cleavage were expressed for each nucleotide
as a ratio or index, [V1(10 M GQC-05)/V1(no GQC-
05)]/[T2(10 M GQC-05)/T2(no GQC-05)]. The frequen-
cies of the logarithm of this index formed a Gaussian dis-
tribution with a mean value of -0.0011 and a standard de-
viation of 0.20 (Supplementary Data). Positions at which
the log (Index) differed by more than two standard devi-
ations from the mean are shown in Figure 5B. The high-
est densities of changes in the secondary structure due to
GQC-05 occurred in the same regions, Q2 and Q5, in which
the secondary structures weremost affected by deazaguano-
sine substitution (29). All of the changes in the Q2 region
produced positive scores, indicating an increase in the pro-
portion of molecules containing the structure, whereas in
the Q5 region there were positive and negative scores, in-
dicative of signiicant re-structuring. Another region with a
high density of changes was the 5′ end, but the signiicance
of the changes is unclear. We conclude that GQC-05 inter-
acted directly with the Q2 and Q5 G4-forming regions in
the Bcl-X-681 RNA.
Interaction of GQC-05 with each G4-forming sequence af-
fects the adjacent 5’SS
The data above show that various G4 ligands affect the
splice sites independently, and that GQC-05 has opposite
effects on the use of the two sites. Moreover, it binds G4-
containing portions of the RNA and affects the structure
of the pre-mRNA in the G4-forming regions Q2 and Q5.
Q2 and Q5 are close to the XS and XL sites, respectively
(Figures 1 and 5B), and it seemed likely that each G4 would
only affect the use of the adjacent site. To test this, the pre-
mRNA was mutated at two positions in each of Q2, Q5
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Figure 5. Direct interaction ofGQC-05withG4-forming sequences. (A) Fluorescence emission spectra of freeGQC-05 (black), andGQC-05 in the presence
of full-length Bcl-X-681 (FL) (red), XS (blue), XL (green), intron (brown) and 3’SS domains (purple). RNAwas incubated at 1 Mwith GQC-05 at 20 M
and excitation was at 321 nm. (B) Mapping of changes in RNase accessibility resulting from incubation with GQC-05 at 1, 5 and 10 M. The nucleotides
marked showed statistically signiicant differences in the value of the cleavage index (see ‘Materials and Methods’ section and Supplementary Data).
and another region, Q4, which does not form a G4 (29).
In each case (Q2.1, Q4.1 and Q5.1, as appropriate) CC was
changed to AA (Supplementary Figure S7). The strategy
(Supplementary Table S4A) was to control for the intercon-
nections between secondary structure and G4 formation by
mutating nucleotides that would affect only the secondary
structure without signiicantly affecting theG4-forming po-
tential. Compensating mutations were then made in each
case to restore base-pairing but disrupt G4 formation (GG
was changed to UU in Q2.2, Q4.2 and Q5.2). To conirm
that these mutations affected GQC-05 interactions, the lu-
orescence emission spectra of the Q2.2 XS and Q5.2 XL
domains were compared with the wild-type sequences. The
emission peaks that we attributed to interaction with G4s
were greatly reduced (Supplementary Figure S8). Splicing
assays were then done in the presence or absence of GQC-
05 (Figure 6).
Although changing the secondary structure potential in
the Qx.1 mutants might affect the equilibrium between sec-
ondary structures, protein binding and G4 formation, G4
formation should still be possible in Q2.1 andQ5.1 and they
should still respond to G600QC-05. However, the relatively
strong stimulation of XS splicing by GQC-05 seen in WT,
Q2.1 and Q4.1 was almost eliminated in Q5.1 (Figure 6 and
Supplementary Table S4B), notwithstanding the fact that
the mutations made were proximal to the XL site. Disrupt-
ing the ability to formG4s inmutants Q2.2 andQ5.2 should
affect the GQC-05 response at whichever site the G4 regu-
lated. Accordingly, disruption of the potential G4 inmutant
Q2.2 prevented the up-regulation of the XS 5’SS by GQC-
05, even though XL was downregulated as usual, and the
disruption of the potential G4 in mutant Q5.2 substantially
reduced the down-regulation of the XL 5’SS by GQC-05.
The small effect of GQC-05 on XS 5’SS up-regulation in
Q5.2 is consistent with the near-loss of the response in mu-
tant Q5.1 (above). We conclude that the interaction of Q2
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Figure 6. Effects on responses to GQC-05 of mutations that disrupt secondary structures or G4s. (A) In vitro splicing assays with mutations in the regions
of Q2, Q4 and Q5. In Q2.1, 4.1 and 5.1, the mutations were intended to disrupt secondary structure but not the putative G4 (Supplementary Figure
S5); in Q2.2, 4.2 and 5.2, the potential secondary structure was restored but the G4-forming potential was reduced. Assays were done in triplicate with
GQC-05 present where shown at 40 M. (B) Relative change in each mutant in the use of the XS 5’SS (the bands were quantiied and corrected for the
radionucleotide content). (C) Corresponding changes in the use of the XL 5’SS.
and Q5 with GQC-05 affects in each case primarily the ad-
jacent 5′ splice site.
DISCUSSION
We have shown here that a range of ellipticine and quin-
doline derivatives exhibit diverse effects on the patterns of
5’SS usage in Bcl-X, while other chemical classes of well-
characterized G4 ligands have no effect. The diversity ap-
pears to be a result of speciic substitutions of the ellipticine
core. GQC-05 has opposite and apparently independent ef-
fects on the two alternative 5’SS, which appear to be the re-
sult of interactions in each case with the adjacent G4. It has
a strikingly greater effect than the other derivatives, indicat-
ing that it forms quite speciic interactions with the G4s.
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Figure 7. Model for the effects of G4s and GQC-05 on the Bcl-X-681 pre-mRNA. The secondary structure is shown as before, with arrows indicating that
the presence of GQC-05 increases the proportion of pre-mRNA adopting the G4 conformations. Further studies will be required to establish whether there
is a dynamic lux, forming an equilibrium distribution, or whether the initial condition adopted is stable for the lifetime of the pre-mRNA. The formation
of a G4 downstream of the XS 5’SS is proposed to destabilize a stem-loop that inhibits use of the XS splice site, while the formation of a G4 overlapping
the XL 5’SS is proposed to directly inhibit use of the 5’SS, possibly by preventing U1 snRNP binding. The mutagenesis data support the proposal for the
XS site but the model is incomplete because it does not explain the effects of mutations near XL on XS splicing.
Given the complexity of the interactions, it is not surpris-
ing that a number of potential ligands had no functional
effects in our assay and that others affected just one site.
Only GQC-05 and closely related molecules showed effects
on both 5′ splice sites (Figures 2 and 3). The degree of speci-
icity was even more striking in assays with HeLa cells (Fig-
ure 4 and Supplementary Table S3). The relatively strin-
gent requirements for GQC-05 activity suggest that only
a minority of RNA G4s will interact with GQC-05 in vivo
and,moreover, suggest that furthermodiications to the side
chains could be tailored to increase eficacy and speciicity
in future.
It is not clear to what extent the putative G4-stabilizing
molecules are binding pre-formedG4s or inducing their for-
mation. If the G4 itself affects splicing, then the assumption
must be that the proportion of molecules in which G4s had
formed is quite low in the absence of the stabilizer, as the sta-
bilizer would otherwise have limited additional effects. The
other, rarely-considered, possibility is that it is the ligand
itself that affects splicing, and that pre-formed G4s recruit
it. Our deazaguanine mapping experiments showed that Q2
and Q5 exist to at least some extent in isolated RNA and in
nuclear extracts (29), and the fact that values of the index
in the Q2 region were all positive in the presence of GQC-
05 suggests that the proportion of G4-containing molecules
increased in the presence of GQC-05. The mixture of posi-
tive and negative scores for Q5 is not inconsistent with the
existence of complex secondary structures that are shifted
toward the G4 by GQC-05. We conclude that GQC-05 is
most likely to act on Bcl-X by increasing the proportion of
the molecules forming G4s (Figure 7), but we note that in
other cases where stabilizers have been used the structures
may not form in the absence of the stabilizer.
There are no general models yet for the mechanisms by
which G4s affect splicing. Q2 is to the 3’ side of the XS
5’SS, which is favored by G4 formation. While G4 forma-
tion would antagonize binding by hnRNP H, it is unlikely
that binding here by hnRNP H would be detrimental. We
note instead that the XS site is at the tip of a long and rela-
tively stable stem-loop. Such structures reduce usage of al-
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ternative 5’SS (46,47). It is likely that GQC-05 stabilizes a
G4 that forms at the expense of the stem, thus increasing
the availability and activity of the XS site.
Q5 is just 5′ to the XL 5’SS, which is inhibited byGQC-05
and, by inference, G4 formation. The inhibition might arise
because the GG/G motif around the 5’SS (shown by /) is
likely to be incorporated into any G4 that might form here.
This is likely to impede binding by U1 snRNP. The fact that
XL is the dominant splice site under normal circumstances
emphasizes that the natural level of G4 formation is low or
that the G4 is transient and the U1 snRNP may enter and
form an irreversible complex. This is consistent with the rel-
atively small number of differences in Q5 between normal
and deazaG-RNA (29) and the relatively large number of
differences in Q5 with and without GQC-05 (Figure 5B).
Amodel assuming that the response to GQC-05 is the re-
sult of enhancing G4 formation at the expense of secondary
structures makes predictions about the effects of the mu-
tations (QX.1, QX.2) on basal as well as GQC-05-induced
splicing patterns. These predictions are shown in Supple-
mentary Table S4A. The effects of mutations in Q2 (Q2.1
and Q2.2) and their responsiveness to GQC-05 are fully in
agreement with a model in which stem-loop formation is in
competition with G4 formation and suppresses XS 5’SS us-
age. In linewith the reasoning above, which suggests that the
XL 5’SS is generally unaffected by either secondary struc-
tures or G4s, the effects of mutations in Q5 do not it the
predictions (Supplementary Table S4B). However, the most
surprising result was that mutations in Q5.1 prevented the
normal increase in usage of the distant XS 5’SS in response
to GQC-05. This might be the result of altered patterns in
protein binding or of altered long-range secondary struc-
tures that are dificult to map. We conclude that the sec-
ondary structure-G4 competition model its the XS site but
not the XL site, and further work will be needed to under-
stand this aspect of regulation by a G4. Given the success
with Q2, however, it would be interesting to map secondary
structures around G4s that have been proposed to affect
splicing in other genes to establish whether this might be
a general mechanism of action of G4 stabilizers.
Finally, we note that GQC-05 was originally selected as
a compound that bound to a DNA G4-forming sequence
in the MYC promoter and induced apoptosis in a Burkitt’s
lymphoma (BL) cell line (39). Another BL cell line in which
translocation had removed the G4-forming sequence was
less sensitive to GQC-05, from which it was inferred that
the MYC promoter was the most sensitive target (39). The
IC50 for the second cell line was still around 13 M, raising
the question as to the mechanisms of toxicity. This question
is especially interesting given that other G4-containing pro-
moters were insensitive to GQC-05 (39). It is possible that
the effects of GQC-05 on the patterns of splicing of Bcl-
X and, possibly, other genes might contribute toward this
effect. It might be possible to tailor the speciicity of G4 lig-
ands that modulate RNA splicing still further to develop
new compounds with therapeutic potential.
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